Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic

Published in: JAMA Network Open, Volume 3, Issue 11 (2020). doi: 10.1001/jamanetworkopen.2020.24984

Posted on RAND.org on January 26, 2021

by Christopher M. Whaley, Megan F. Pera, Jonathan Cantor, Jennie Chang, Julia Velasco, Heather K. Hagg, Neeraj Sood, Dena M. Bravata

Read More

Access further information on this document at JAMA Network Open

This article was published outside of RAND. The full text of the article can be found at the link above.

Importance

The coronavirus disease 2019 (COVID-19) pandemic has placed unprecedented strain on patients and health care professionals and institutions, but the association of the pandemic with use of preventive, elective, and nonelective care, as well as potential disparities in use of health care, remain unknown.

Objective

To examine changes in health care use during the first 2 months of the COVID-19 pandemic in March and April of 2020 relative to March and April of 2019 and 2018, and to examine whether changes in use differ by patient's zip code-level race/ethnicity or income.

Design, Setting, and Participants

This cross-sectional study analyzed health insurance claims for patients from all 50 US states who receive health insurance through their employers. Changes in use of preventive services, nonelective care, elective procedures, prescription drugs, in-person office visits, and telemedicine visits were examined during the first 2 months of the COVID-19 pandemic in 2020 relative to existing trends in 2019 and 2018. Disparities in the association of the pandemic with health care use based on patient's zip code-level race and income were also examined. Results: Data from 5.6, 6.4, and 6.8 million US individuals with employer-sponsored insurance in 2018, 2019, and 2020, respectively, were analyzed. Patient demographics were similar in all 3 years (mean [SD] age, 34.3 [18.6] years in 2018, 34.3 [18.5] years in 2019, and 34.5 [18.5] years in 2020); 50.0% women in 2018, 49.5% women in 2019, and 49.5% women in 2020). In March and April 2020, regression-adjusted use rate per 10,000 persons changed by –28.2 (95% CI, –30.5 to –25.9) and –64.5 (95% CI, –66.8 to –62.2) for colonoscopies; –149.1 (95% CI, –162.0 to –16.2) and –342.1 (95% CI, –355.0 to –329.2) for mammograms; –60.0 (95% CI, –63.3 to –54.7) and –118.1 (95% CI, –112.4 to –113.9) for hemoglobin A1c tests; –300.5 (95% CI, –346.5 to –254.5) and –369.0 (95% CI, –414.7 to –323.4) for child vaccines; –4.6 (95% CI, –5.3 to –3.9) and –10.9 (95% CI, –11.6 to –10.2) for musculoskeletal surgery; –1.1 (95% CI, –1.4 to –0.7) and –3.4 (95% CI, –3.8 to –3.0) for cataract surgery; –13.4 (95% CI, –14.6 to –12.2) and –31.4 (95% CI, –32.6 to –30.2) for magnetic resonance imaging; and –581.1 (95% CI, –612.9 to –549.3) and –1465 (95% CI, –1496 to –1433) for in-person office visits. Use of telemedicine services increased by 227.9 (95% CI, 221.7 to 234.1) per 10,000 persons and 641.6 (95% CI, 635.5 to 647.8) per 10,000 persons. Patients living in zip codes with lower-income or majority racial/ethnic minority populations experienced smaller reductions in in-person visits (=80% racial/ethnic minority zip code: 200.0 per 10,000 [95% CI, 128.9–270.1]; 79%–21% racial/ethnic minority zip code: 54.2 per 10,000 [95% CI, 33.6–74.9]) but also had lower rates of adoption of telemedicine (=80% racial/ethnic minority zip code: –71.6 per 10,000 [95% CI, –87.6 to –55.5]; 79%–21% racial/ethnic minority zip code: –15.1 per 10,000 [95% CI, –19.8 to –10.4]).

Conclusions and Relevance

In this cross-sectional study of a large US population with employer-sponsored insurance, the first 2 months of the COVID-19 pandemic were associated with dramatic reductions in the use of preventive and elective care. Use of telemedicine increased rapidly but not enough to account for reductions in in-person primary care visits. Race and income disparities at the zip code level exist in use of telemedicine.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.